Jim Cramer Advises His Viewers On Ionis Pharmaceuticals Inc and Sarepta Therapeutics Inc

Jim Cramer said on

that he doesn't want to recommend speculative stocks as

. He thinks that the stock is a hold, but it is not a buy. Cramer thinks that it might be a good idea to buy call options in

, because its drug might get approved. He believes that it can trade up a lot if that happens, but it can also decline a lot if it doesn't get approved. He wants to use options to make a bullish bet and limit his risk.